We hypothesize that the mutation and copy number loss of TP53, a key tumor suppressor gene, reduce the inhibition of tumor suppressor genes, which could be the key to promoting the upregulation of m6A binding protein in breast cancer. Here, TP53 is linked to breast carcinoma.